Educational

Anxiety disorders are among the most common mental health conditions, but they are also remarkably diverse. Generalized anxiety, panic, social anxiety, trauma-related symptoms, and anxiety associated with serious illness can look very different from one another and may respond differently to treatment. As interest in psychedelic-assisted therapy has grown, researchers have begun examining whether psilocybin […]

Interest in psychedelic-assisted therapy has grown rapidly over the past decade, fueled by research into treatments such as psilocybin, MDMA, and ketamine. News headlines often highlight promising study results, leading many people to wonder whether these therapies are already proven to work. The reality is more nuanced. Clinical trials are the reason we know as […]

Interest in psychedelic-assisted therapy has grown rapidly as researchers continue studying treatments such as psilocybin, MDMA, and ketamine for a variety of mental health conditions. However, one of the most important things to understand is that these therapies are not appropriate for everyone. Determining whether someone may be a good candidate requires a comprehensive medical […]

Depression affects millions of people each year, and while many individuals improve with psychotherapy, medication, or a combination of both, others continue to experience symptoms despite trying multiple treatments. This has led researchers to investigate new approaches for treatment-resistant depression (TRD), including psilocybin-assisted therapy. Over the past decade, early clinical studies have generated significant interest […]

As research into psychedelic-assisted therapy continues to expand, many mental health professionals are preparing for a future in which treatments such as MDMA and psilocybin may become more widely available. Interestingly, much of this preparation is happening before broad legalization or widespread clinical availability. Across the United States—and particularly in California—psychologists, psychiatrists, therapists, and healthcare […]

One of the most common questions people ask about psychedelic-assisted therapy is simple: “Will my insurance cover it?” The answer depends on the specific treatment, your insurance plan, where you receive care, and whether the therapy has been approved for that particular condition. While interest in psychedelic-assisted therapy continues to grow, insurance coverage has not […]

Eating disorders are among the most serious mental health conditions, affecting millions of people worldwide. While many individuals benefit from evidence-based treatments such as psychotherapy, nutritional rehabilitation, and medical care, recovery can be challenging, and relapse is common. As psychedelic-assisted therapy research has expanded, scientists have begun exploring whether treatments like psilocybin might eventually play […]

Obsessive-compulsive disorder (OCD) can be one of the most challenging mental health conditions to treat. While many people experience meaningful improvement with cognitive behavioral therapy (CBT), Exposure and Response Prevention (ERP), and medication, others continue to struggle despite trying multiple evidence-based treatments. As interest in psychedelic-assisted therapies has grown, researchers have begun studying whether treatments […]

As interest in psychedelic therapy continues to grow, you’ve probably noticed one phrase appearing again and again: Psychedelic-assisted therapy. At first glance, it may seem like another way of saying “psychedelic therapy.” In reality, the word assisted is one of the most important parts of the phrase. It reflects a fundamental idea shared across much […]

Depression affects millions of people every year, and while many individuals improve with psychotherapy, antidepressant medications, lifestyle changes, or a combination of treatments, not everyone experiences meaningful relief. For some people, depression continues despite multiple attempts at treatment. When this occurs, healthcare professionals may use the term treatment-resistant depression (TRD). Understanding what treatment-resistant depression means—and […]